Episode 2 - The future is now-combination therapies in DLBCL

from Bridges - Advances in Cancer Therapeutics · host ADC Therapeutics

Interested in novel combination therapies for patients with diffuse large B-cell lymphoma (DLBCL)? Dr. Marie Hu joins the podcast to share her perspectives on emerging treatments and the impact of stronger academic-community collaborations on patient care for relapsed and refractory patients with DLBCL.Co-hosts: Dr. Matthew Lunning, MD, University of Nebraska Medical Center, and Dr. Tara Graff, MD, Mission Cancer & BloodGuest: Dr. Marie Hu, Assistant Professor of Medicine, University of Minnesota

Episode metadata supplied by the publisher feed · Published Nov 24, 2025

Embed this episode

Attribution link and audio player

Ready to play

Episode 2 - The future is now-combination therapies in DLBCL

0:00 18:09

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Bridges - Advances in Cancer Therapeutics?

This episode is 18 minutes long.

When was this Bridges - Advances in Cancer Therapeutics episode published?

This episode was published on November 24, 2025.

Can I download this Bridges - Advances in Cancer Therapeutics episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!